SLC2A1 and cancer: Quantitative PCR analysis of MCF7 cells conducted 3 h after inhibitor treatment revealed that the expression of GLUT1, which is reported to be a highly expressed glucose transporter gene in cancer cell lines [29], increased significantly by 1.5- to 1.7-fold following inhibitor treatment (Figure 2b).